NERV
Minerva Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.32
−1.28%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.19
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +12.2%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$0.19 | -$0.14 | Beat 27.58% | — |
| May 5, 2026 | -$0.13 | -$0.17 | Miss -30.77% | — |
| Nov 5, 2025 | -$0.35 | -$0.36 | Miss -2.86% | — |
| Aug 14, 2025 | -$0.95 | -$0.43 | Beat 54.74% | — |
| May 1, 2024 | -$1.20 | -$1.13 | Beat 5.83% | — |
| Feb 22, 2024 | -$0.88 | -$1.19 | Miss -35.23% | — |
| Aug 1, 2023 | -$0.44 | -$1.12 | Miss -154.55% | — |
| May 15, 2023 | -$1.63 | -$1.31 | Beat 19.63% | — |
| Mar 8, 2023 | -$1.35 | -$1.26 | Beat 6.67% | — |
| Nov 9, 2022 | -$1.46 | -$1.29 | Beat 11.64% | — |
| Aug 9, 2022 | -$1.84 | -$1.63 | Beat 11.41% | — |
| May 4, 2022 | -$1.60 | -$1.84 | Miss -15.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026